CBIO CRESCENT BIOPHARMA, INC.: institutional ownership and insider trading
86 funds reported holding $530M of CRESCENT BIOPHARMA, INC. in their latest 13F filings; in Q2 2026 funds net bought $72.0M, with 32 new positions and 12 funds selling out; over the last 12 months insiders bought $30.6M and sold $1.51M on the open market.
CBIO revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0, net income −$24.8M
- Quarter ended Mar 31, 2026: revenue $1.04M, net income −$23.3M
- Quarter ended Dec 31, 2025: revenue n/a, net income −$23.3M
- Quarter ended Sep 30, 2025: revenue n/a, net income −$24.6M
Famous investors holding CBIO
- Izzy Englander (Millennium Management): $7.27M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $3.36M, 0.0% of the portfolio
Largest institutional holders of CBIO
- FMR LLC — $74.4M
- BVF INC/IL — $49.5M
- Fairmount Funds Management LLC — $49.5M
- VR Adviser, LLC — $38.4M
- Logos Global Management LP — $34.2M
- FCPM III SERVICES B.V. — $30.2M
- BALYASNY ASSET MANAGEMENT L.P. — $29.9M
- Vestal Point Capital, LP — $29.3M
- Opaleye Management Inc. — $23.7M
- BlackRock, Inc. (BLK) — $22.9M
Recent CBIO insider trades
- Sep 18, 2026: McNeill Jonathan sold 4,570 shares ($77.2K)
- Sep 18, 2026: Brumm Joshua T sold 9,447 shares ($160K)
- Sep 16, 2026: Bispham Barbara Harlin sold 620 shares ($11.1K)
- Sep 16, 2026: Scalzo Richard William sold 568 shares ($10.2K)
5%+ owners
- Peter Harwin: 16.5% (Schedule 13D/A, filed Jul 20, 2026)
Who owns the most CBIO stock?
The largest institutional holders of CRESCENT BIOPHARMA, INC. in the latest 13F filings are FMR LLC ($74.4M), BVF INC/IL ($49.5M), Fairmount Funds Management LLC ($49.5M).
Are insiders buying or selling CBIO?
Over the last 12 months insiders bought $30.6M and sold $1.51M of CRESCENT BIOPHARMA, INC. stock on the open market (SEC Form 4).
Which famous investors own CBIO?
Izzy Englander, Two Sigma.
What was CBIO's revenue last quarter?
CRESCENT BIOPHARMA, INC. reported revenue of $0 for the quarter ended June 30, 2026, with net income of −$24.8M.